Product Information
INVEGA HAFYERA 1,092 MG/3.5 ML is a brand product labeled by Janssen Pharmaceuticals Inc., priced at $4018.0637 per ML under NDC 50458061101. Its NADAC has been published 62 times since Jun 18, 2025.
FDA first approved this application on May 18, 2015.
Strength
1092 mg/3.5mL
Manufacturer
Janssen Pharmaceuticals Inc.NDC
50458061101
Classification
Brand
Dosage Form
INJECTION, SUSPENSION, EXTENDED RELEASE
Route
INTRAMUSCULAR
Effective Date
1/2/2026
Active Ingredients
PALIPERIDONE PALMITATEApproval Type
New Drug (NDA)
FDA Application
NDA207946FDA Approved
5/18/2015
On Market Since
8/30/2021
Pharmacological Classes
Price Statistics
The NADAC for INVEGA HAFYERA 1,092 MG/3.5 ML has been published 62 times since Jun 18, 2025, and over the history we have for it it has risen 2.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4018.0637 per ML |
|---|---|
| All-time high | $4018.0637 (Aug 19, 2026) |
| All-time low | $3916.3960 (Jun 18, 2025) |
| 52-week high | $4018.0637 |
| 52-week low | $3916.3960 |
| Median price | $4018.0637 |
| Average price | $3970.8353 |
| Largest weekly change | +2.4% (Jan 14, 2026) |
| Weeks tracked | 62 |
| Tracking since | Jun 18, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the paliperidone palmitate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of INVEGA HAFYERA 1,092 MG/3.5 ML?
The current National Average Drug Acquisition Cost (NADAC) for INVEGA HAFYERA 1,092 MG/3.5 ML, manufactured by Janssen Pharmaceuticals Inc., is $4018.0637 per ML (NDC 50458061101), effective Aug 19, 2026.
How has the price of INVEGA HAFYERA 1,092 MG/3.5 ML changed over time?
Over the history we have for it, the NADAC for INVEGA HAFYERA 1,092 MG/3.5 ML has risen 2.6%. It has been tracked across 62 weekly CMS publications since Jun 18, 2025.
What are the highest and lowest recorded NADAC prices for INVEGA HAFYERA 1,092 MG/3.5 ML?
Since Jun 18, 2025, the NADAC for INVEGA HAFYERA 1,092 MG/3.5 ML has ranged from a low of $3916.3960 (Jun 18, 2025) to a high of $4018.0637 (Aug 19, 2026), with a median of $4018.0637 per ML.
Are there cheaper alternatives to INVEGA HAFYERA 1,092 MG/3.5 ML?
No other NADAC-published product currently shares the active ingredient and strength of INVEGA HAFYERA 1,092 MG/3.5 ML in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures INVEGA HAFYERA 1,092 MG/3.5 ML?
INVEGA HAFYERA 1,092 MG/3.5 ML (NDC 50458061101) is labeled by Janssen Pharmaceuticals Inc., and CMS classifies it as a brand product.